Precision BioSciences Inc (DTIL)
7.70
-0.38
(-4.70%)
USD |
NASDAQ |
Nov 14, 16:00
7.70
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Free Cash Flow: -48.36M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -48.36M |
| June 30, 2024 | -65.91M |
| March 31, 2024 | -73.27M |
| December 31, 2023 | -86.39M |
| September 30, 2023 | -100.45M |
| June 30, 2023 | -48.82M |
| March 31, 2023 | -51.57M |
| December 31, 2022 | -49.07M |
| September 30, 2022 | -51.78M |
| June 30, 2022 | -105.27M |
| March 31, 2022 | -113.29M |
| December 31, 2021 | -16.66M |
| Date | Value |
|---|---|
| September 30, 2021 | -6.018M |
| June 30, 2021 | -3.90M |
| March 31, 2021 | 1.543M |
| December 31, 2020 | -92.42M |
| September 30, 2020 | -103.95M |
| June 30, 2020 | -100.58M |
| March 31, 2020 | -97.70M |
| December 31, 2019 | -95.68M |
| September 30, 2019 | -92.38M |
| June 30, 2019 | -91.59M |
| March 31, 2019 | -77.32M |
| December 31, 2018 | -67.40M |
Free Cash Flow Range, Past 5 Years
-113.29M
Minimum
Mar 2022
1.543M
Maximum
Mar 2021
-65.48M
Average
-69.59M
Median
Free Cash Flow Benchmarks
| Assembly Biosciences Inc | 24.10M |
| TG Therapeutics Inc | -28.11M |
| Protagonist Therapeutics Inc | 229.23M |
| Alector Inc | -222.26M |
| Entrada Therapeutics Inc | -17.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.912M |
| Cash from Investing (Quarterly) | -0.064M |
| Cash from Financing (Quarterly) | 3.733M |
| Free Cash Flow Per Share (Quarterly) | -0.8201 |
| Free Cash Flow to Equity (Quarterly) | -5.76M |
| Free Cash Flow Yield | -107.5% |